“Pharmacotherapy with high doses of methotrexate (HDMTX) in oncology – how should chemotherapy be conducted based on therapeutic drug monitoring?”, Prospect. Pharm. Sci., vol. 21, no. 4, pp. 40–47, Nov. 2023, doi: 10.56782/pps.167.